Role of melatonin receptor mt2 and quinone reductase ii in the regulation of the redox status of 3t3-l1 preadipocytes in vitro

Cell Biology International

Volumn 37, Issue 8, 2013, Pages 835-842

  Adamczyk Sowa, Monika ^a   Sowa, Pawel ^a   Zwirska Korczala, Krystyna ^a   Pierzchala, Krystyna ^a   Bartosz, Grzegorz ^b,c   Sadowska Bartosz, Izabela ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b UNIVERSITY OF RZESZÓW   (Poland)

^c UNIVERSITY OF LODZ   (Poland)

Author keywords

3T3 L1 preadipocytes; Antioxidant enzymes; Luzindole; Melatonin; Oxidative stress; Prazosin

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LUZINDOLE; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; MELATONIN; MELATONIN 2 RECEPTOR; PRAZOSIN; QUINONE REDUCTASE II; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL STRAIN 3T3 L1; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; IN VITRO STUDY; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 84880672674     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10105     Document Type: Article

References (40)

1. Aebi H (1984) Catalase in vitro. Methods Enzymol 105: 121-6.
2. Alvarez M (1991) 3T3 cells in adipocytic conversion. Arch Invest Med (Mex) 22: 235-41.
3. Alonso-Vale MI, Peres SB, Vernochet C, Farmer SR, Lima FB (2009) Adipocyte differentiation is inhibited by melatonin through the regulation of C/EBPbeta transcriptional activity. J Pineal Res 47: 221-7.
4. Boutin JA, Saunier C, Guenin SP, Berger S,Moulharat N, Gohier A, Delagrange P, Cogé F, Ferry G (2008) Studies of the melatonin binding site location onto quinone reductase 2 by directed mutagenesis. Arch Biochem Biophys 477: 12-9.
5. Brydon L, Petit L, Delagrange P, Strosberg AD, Jockers R (2001) Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes. Endocrinology 142: 4264-71.
6. Carlberg I, Mannervik B (1985) Glutathione reductase. Methods Enzymol 113: 485-90.
7. Cinti S (2012) The adipose organ at a glance. Dis Model Mech 5: 588-94.
8. Crespo I, Miguel BS, Laliena A, Alvarez M, Culebras JM, González-Gallego J, Tuñón MJ (2010) Melatonin prevents the decreased activity of antioxidant enzymes and activates nuclear erythroid 2-related factor 2 signaling in an animal model of fulminant hepatic failure of viral origin. J Pineal Res 49: 193-200.
9. Devavry S, Legros C, Brasseur C, CohenW, Guenin SP, Delagrange P, Malpaux B, Ouvry C, Cogé F, Nosjean O, Boutin JA (2012) Molecular pharmacology of the mouse melatonin receptors MT1 and MT2. Eur J Pharmacol 677: 15-21.
10. Ekmekcioglu C (2006) Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother 60: 97-108.
11. Faridbod F, Ganjali MR, Larijani B, Nasli-Esfahani E, Riahi S, Norouzi P (2010) Quantitative analysis of Prazosin hydrochloride in pharmaceutical formulation by prazosin potentiometric sensor based on computational investigation. Int J Electrochem Sci 5: 653-67.
12. Fischer TW, Kleszczyński K, Hardkop LH, Kruse N, Zillikens D (2013) Melatonin enhances antioxidative enzyme gene expression (CAT, GPx, SOD), prevents their UVR-induced depletion, and protects against the formation of DNA damage (8-hydroxy-2'-deoxyguanosine) in ex vivo human skin. J Pineal Res 54: 303-12.
13. García-Macia M, Vega-Naredo I, De Gonzalo-Calvo D, Rodríguez-González SM, Camello PJ, Camello-Almaraz C, Martín-Cano FE, Rodríguez-Colunga MJ, Pozo MJ, Coto-Montes AM (2011) Melatonin induces neural SOD2 expression independent of the NF-kappaB pathway and improves the mitochondrial population and function in old mice. J Pineal Res 50: 54-63.
14. González A, Alvarez-García V, Martínez-Campa C, Alonso-González C, Cos S (2012) Melatonin promotes differentiation of 3T3-L1 fibroblasts. J Pineal Res 52: 12-20.
15. Harasimowicz J, Marques KL, Silva AF, Costa RC, Prior JA, Rodrigues SS, Santos JL (2012) Chemiluminometric evaluation of melatonin and selected melatonin precursors' interaction with reactive oxygen and nitrogen species. Anal Biochem 420: 1-6.
16. Jaworek J, Konturek SJ, Leja-Szpak A, Nawrot K, Bonior J, Tomaszewska R, Stachura J, Pawlik WW (2002) Role of endogenous melatonin and its MT2 receptor in the modulation of caerulein-induced pancreatitis in the rat. J Physiol Pharmacol 53(4 Pt 2): 791-804.
17. Jaworek J, Szklarczyk J, Jaworek AK, Nawrot-Porabka K, Leja-Szpak A, Bonior J, Kot M (2012) Protective effect of melatonin on acute pancreatitis. Int J Inflam 2012: 173675.
18. Kedziora-Kornatowska K, Szewczyk-Golec K, Kozakiewicz M, Pawluk H, Czuczejko J, Kornatowski T, Bartosz G, Kedziora J (2009) Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients. J Pineal Res 46: 333-7.
19. Kharwar RK, Haldar C (2012) Daily variation in antioxidant enzymes and lipid peroxidation in lungs of a tropical bird Perdicula asiatica: role of melatonin and nuclear receptor RORa. Comp Biochem Physiol A Mol Integr Physiol 162: 296-302.
20. Khoshbaten A, Ferrell WR (1993) Nerve-mediated responses of blood vessels in the rabbit knee joint. J Vasc Res 30: 102-7.
21. Luchetti F, Canonico B, Betti M, Arcangeletti M, Pilolli F, Piroddi M, Canesi L, Papa S, Galli F (2010)Melatonin signaling and cell protection function. FASEB J 24: 3603-24.
22. Maitra D, Abdulhamid I, Diamond MP, Saed GM, Abu-Soud HM (2012)Melatonin attenuates hypochlorous acid-mediated heme destruction, free iron release, and protein aggregation in hemoglobin. J Pineal Res 53: 198-205.
23. Murawska-Cialowicz E, Jethon Z, Magdalan J, Januszewska L, Podhorska-Okolów M, Zawadzki M, Sozański T, Dziegiel P (2011) Effects of melatonin on lipid peroxidation and antioxidative enzyme activities in the liver, kidneys and brain of rats administered with benzo(a)pyrene. Exp Toxicol Pathol 63: 97-103.
24. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-8.
25. Oxenkrug GF, Bachurin SO, Prakhie IV, Zefirov NS (2010) Quinone reductase 2 and antidepressant effect of melatonin derivatives. Ann N Y Acad Sci 1199: 121-4.
26. Oyanagui Y (1984) Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal Biochem 142: 290-6.
27. Paglia D, Valentine W (1967) Studies on the quantitive and qualitative characterization of erythrocyte glutatione peroxidase. J Lab Clin Med 70: 158-69.
28. Pegan SD, Sturdy M, Ferry G, Delagrange P, Boutin JA,Meseca AD (2011) X-ray structural studies of quinone reductase 2 nanomolar range inhibitors. Protein Sci 20: 1182-95.
29. Radio NM, Doctor JS, Witt-Enderby PA (2006) Melatonin enhances alkaline phosphatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade. J Pineal Res 40: 332-42.
30. Rastmanesh R, de Bruin PF (2012) Potential of melatonin for the treatment or prevention of obesity: an urgent need to include weight reduction as a secondary outcome in clinical trials of melatonin in obese patients with sleep disorders. Contemp Clin Trials 33: 574-575.
31. Reiter RJ, Tan DX, Manchester LC, Lopez-Burillo S, Sainz RM, Mayo JC (2003) Melatonin: detoxification of oxygen and nitrogen-based toxic reactants. Adv Exp Med Biol 527: 539-48.
32. Sánchez-Sánchez AM, Martín V, García-Santos G, Rodríguez-Blanco J, Casado-Zapico S, Suarez-Garnacho S, Antolín I, Rodriguez C (2011) Intracellular redox state as determinant for melatonin antiproliferative vs cytotoxic effects in cancer cells. Free Radic Res 45: 1333-41.
33. Slominski A, Fischer TW, Zmijewski MA, Wortsman J, Semak I, Zbytek B, Slominski RM, Tobin DJ (2005) On the role of melatonin in skin physiology and pathology. Endocrine 27: 137-48.
34. Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS, Slominski AT (2012) Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol 351: 152-66.
35. Szaroma W, Dziubek K (2011) Changes in the amount of reduced glutathione and activity of antioxidant enzymes in chosen mouse organs influenced by zymosan and melatonin administration. Acta Biol Hung 62: 133-41.
36. Tan DX, Manchester LC, Fuentes-Broto L, Paredes SD, Reiter RJ (2011) Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev 12: 167-88.
37. Tan S, Curtis-Prior PB (1984) Anti-lipolytic action of prazosin in hamster fat cells. Pharmacol Res Commun 16: 451-9.
38. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-808.
39. Vella F, Ferry G, Delagrange P, Boutin JA (2005) NRH: quinone reductase 2: an enzyme of surprises and mysteries. Biochem Pharmacol 71: 1-12.
40. Zwirska-Korczala K, Jochem J, Adamczyk-Sowa M, Sowa P, Polaniak R, Birkner E, Latocha M, Pilc K, Suchanek R (2005) Influence of melatonin on cell proliferation, antioxidative enzyme activities and lipid peroxidation in 3T3-L1 preadipocytes-an in vitro study. Physiol Pharmacol 56 (Suppl. 6): 91-99.